Interaction of the δ-aminolevulinic acid dehydratase polymorphism and lead burden on cognitive function: The VA normative aging study

Journal of Occupational and Environmental Medicine

Volumn 50, Issue 9, 2008, Pages 1053-1061

  Rajan, Pradeep ^a,k   Kelsey, Karl T ^a,b   Schwartz, Joel D ^a,c   Bellinger, David C ^a,d   Weuve, Jennifer ^a   Spiro III, Avron ^e,f,g   Sparrow, David ^e,g,h   Smith, Thomas J ^a   Nie, Huiling ^a   Weisskopf, Marc G ^a,c   Hu, Howard ^a,c,i   Wright, Robert O ^a,c,j  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BROWN UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f BOSTON UNIVERSITY   (United States)

^g BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^j BOSTON CHILDREN S HOSPITAL   (United States)

^k NONE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LEAD; PORPHOBILINOGEN SYNTHASE; ENZYME;

ADULT; AGED; AGING; ARTICLE; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; GENE INTERACTION; GENOTYPE; HETEROZYGOTE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OCCUPATIONAL EXPOSURE; BODY BURDEN; BONE; COGNITIVE DEFECT; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETICS; GOVERNMENT; LEAD POISONING; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; AGING; BODY BURDEN; BONE AND BONES; COGNITION DISORDERS; ENZYMES; HUMANS; LEAD; LEAD POISONING; MALE; MASSACHUSETTS; MIDDLE AGED; POLYMORPHISM, GENETIC; PORPHOBILINOGEN SYNTHASE; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; YOUNG ADULT;

EID: 62649137806     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3181792463     Document Type: Article

References (36)

1. Hanninen H, Aitio A, Kovala T, et al. Occupational exposure to lead and neuropsychological dysfunction. Occup Environ Med. 1998;55:202-209.
2. Stewart WF, Schwartz BS, Simon D, Bolla KI, Todd AC, Links J. Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers. Neurology. 1999;52:1610-1617.
3. Schwartz BS, Lee BK, Lee GS, et al. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. Am J Epidemiol. 2001;153:453-464.
4. Barth A, Schaffer AW, Osterode W, et al. Reduced cognitive abilities in lead-exposed men. Int Arch Occup Environ Health. 2002;75:394-398.
5. Schwartz BS, Lee BK, Bandeen-Roche K, et al. Occupational lead exposure and longitudinal decline in neurobehavioral test scores. Epidemiology. 2005;16:106-113.
6. Shih R, Hu H, Weisskopf MG, Schwartz BS. Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ Health Perspect. 2007;115:483-492.
7. Shih RA, Glass TA, Bandeen-Roche K, et al. Environmental lead exposure and cognitive function in community-dwelling older adults. Neurology. 2006;67: 1556-1562.
8. Weisskopf MG, Proctor SP, Wright RO, et al. Cumulative lead exposure and cognitive performance among elderly men. Epidemiology. 2007;18:59-66.
9. Wetmur JG, Kaya AH, Plewinska M, Desnick RJ. Molecular characterization of the human delta-aminolevulinic acid dehydratase 2 (ALAD2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning. Am J Hum Genet. 1991;49: 757-763.
10. Kelada SN, Shelton E, Kaufmann RB, Khoury MJ. Delta-aminolevulinic acid dehydratase genotype and lead toxicity: a HuGE review. Am J Epidemiol. 2001; 154:1-13.
11. Wu MT, Kelsey K, Schwartz J, Sparrow D, Weiss S, Hu H. A delta-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: The Normative Aging Study. Environ Health Perspect. 2003; 111:335-340.
12. Weaver VM, Schwartz BS, Jaar BG, et al. Associations of uric acid with polymorphisms in the delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers. Environ Health Perspect. 2005;113:1509-1515.
13. Weaver VM, Lee BK, Todd AC, et al. Effect modification by delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase gene polymorphisms on associations between patella lead and renal function in lead workers. Environ Res. 2006;102:61-69.
14. Bellinger D, Hu H, Titlebaum L, Needleman HL. Attentional correlates of dentin and bone lead levels in adolescents. Arch Environ Health. 1994;49:98-105.
15. Chia SE, Yap E, Chia KS. Delta-aminolevulinic acid dehydratase (ALAD) polymorphism and susceptibility of workers exposed to inorganic lead and its effects on neurobehavioral functions. Neurotoxicology. 2004;25:1041-1047.
16. Louis ED, Applegate L, Graziano JH, Parides M, Slavkovich V, Bhat KH. Interaction between blood lead concentration and delta-aminolevulinate dehydratase gene polymorphisms increases the odds of essential tumor. Mov Disord. 2005;20: 1170-1177.
17. Weuve J, Kelsey KT, Schwartz J, et al. Delta-aminolevulinic acid dehydratase (ALAD) polymorphism and the relation between low-level lead exposure and the mini-mental status examination in older men: the Normative Aging Study. Occup Environ Med. 2006;63:746-753.
18. Rajan P, Kelsey KT, Schwartz JD, et al. Lead burden and psychiatric symptoms and the modifying influence of the δ-aminolevulinic acid dehydratase polymorphism: the Normative Aging Study. Am J Epidemiol. 2007;166:1400-1408.
19. Bell B, Rose CL, Damon A. The veterans administration longitudinal study of healthy aging. Gerontologist. 1966;6: 179-184.
20. Payton M, Riggs KM, Spiro A III, Weiss ST, Hu H. Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. Neurotoxicol Teratol. 1998;20:19-27.
21. Cheng Y, Willett WC, Schwartz J, Sparrow D, Weiss S, Hu H. Relation of nutrition to bone lead and blood lead levels in middle-aged to elderly men. The Normative Aging Study. Am J Epidemiol. 1998;147:1162-1174.
22. Aro A, Todd A, Amarasiriwardena C, Hu H. Improvements in the calibration of 109Cd K x-ray fluorescence systems for measuring bone lead in vivo. Phys Med Biol. 1994;39:2263-2271.
23. Hu H, Rabinowitz M, Smith D. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect. 1998;106:1-8.
24. Schwartz BS, Lee BK, Stewart W. Associations of delta-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. Am J Epidemiol. 1995;142:738-745.
25. Letz R. NES2 User's Manual (Version 4.4). Winchester, MA: Neurobehavioral Systems, Inc; 1991.
26. Morris JC, Heyman A, Mohs RC, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39:1159-1165.
27. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York: Harcourt, Brace Janovich; 1981.
28. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2004.
29. Wood SN. Stable and efficient multiple smoothing parameter estimation for generalized additive models. J Am Stat Assoc. 2004;99:637-686.
30. Weisskopf MG, Wright RO, Schwartz J, et al. Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study. Am J Epidemiol. 2004;160:1184-1193.
31. Hatcher L. A Step-by-Step Approach to Using the SAS System for Factor Analysis and Structural Equation Modeling. 1st ed. Cary, NC: SAS Publishing; 1994.
32. Bergdahl IA, Grubb A, Schutz A. Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol. 1997;81:153-158.
33. Suzen HS, Duydu Y, Aydin A, Isimer A, Vural N. Influences of the delta-aminolevulinic acid dehydratase (ALAD) polymorphism on biomarkers of lead exposure in turkish storage battery manufacturing workers. Am J Ind Med. 2003;43:165-171.
34. Jaffe EK, Volin M, Bronson-Mullins CR, et al. An artificial gene for human porphobilinogen synthase allows comparison of an allelic variation implicated in susceptibility to lead poisoning. J Biol Chem. 2000;275:2619-2626.
35. Hu H, Wu MT, Cheng Y, Sparrow D, Weiss S, Kelsey K. The delta-aminolevulinic dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study. Environ Health Perspect. 2001;109:827-832.
36. Hu H. Bone lead as a new biological marker of lead dose: recent findings and implications for public health. Environ Health Perspect. 1998;106:961-967.